Michael J. Brooks - Jul 20, 2023 Form 4/A - Amendment Insider Report for Edesa Biotech, Inc. (EDSA)

Role
President
Signature
/s/ Michael J. Brooks
Stock symbol
EDSA
Transactions as of
Jul 20, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/24/2023, 04:46 PM
Date Of Original Report
Jul 21, 2023
Previous filing
Nov 4, 2022
Next filing
Aug 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDSA Share Option (right to buy) Award $0 +80K $0.00 80K Jul 20, 2023 Common Shares 80K $0.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests monthly in equal proportions over 36 months beginning on the date of grant.

Remarks:

This amendment on Form 4/A is being filed to amend the Form 4 filed on July 21, 2023, solely to correct an administrative error in the expiration date of the Share Option previously reported in Column 6 of Table II.